Fundraising FoxNovai
Reading, GB · Founded 2020 · 9 known investors
Find your way into Novai
Sign up to see every warm intro you have to Novai
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novai team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
Founders & leadership
Novai was founded in 2020 by Prof. Francesca Cordeiro, Prof. M. Francesca Cordeiro, and MARIA FRANCESCA CORDEIRO.
Board
Investors · 9
How we know: Anglia Capital Group's portfolio page · Not right? Tell us
How we know: Ascension's portfolio page · Not right? Tell us
How we know: ExSight Ventures's portfolio page · funding news · Not right? Tell us
How we know: The FSE Group's portfolio page · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$1.1M disclosed across 1 of 2 rounds · 2023–2025
- Undisclosed amountSeries BMar 2025
Export Development Canada (lead), Graham Partners, InBC Investment Corp, Seaspan
Source ↗
▶$1.1MraisedMay 2023 · 22 investors · BiotechnologyRule 506(b)
- NATALIE PANKOVADirector
- STEPHEN ROY PAGEDirector
- MARIA FRANCESCA CORDEIRODirector
- KARL DAVID KEEGANDirector
- CHRISTOPHER MARK WHEATCROFTDirector
- JAMES HEDLEY RAWLINGSONDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Jan 2023
- Incorporated
- Other, United Kingdom, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Companies House · registry record
View on Companies House ↗- Registered name
- NOVAI LTD
- Company number
- 12457690
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 12 Feb 2020
- Registered office
- 9 Greyfriars Road, Reading, Berkshire, RG1 1NU
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 11 Mar 2026 · next due 25 Mar 2027
Current officers · 4
- Maria Francesca Cordeiro — director, appointed 12 Feb 2020
- Stephen Roy Page — director, appointed 28 Feb 2022
- Natalie Pankova — director, appointed 13 Dec 2020
- Christopher Mark Wheatcroft — director, appointed 28 Feb 2022
Source: Companies House public register · retrieved 30 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Novai do?
- Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
- Who founded Novai?
- Novai was founded by Prof. Francesca Cordeiro, Prof. M. Francesca Cordeiro, MARIA FRANCESCA CORDEIRO in 2020.
- Who are Novai's investors?
- Novai's investors include Anglia Capital Group, Ascension, ExSight Ventures, The FSE Group, InBC Investment Corp., Zinc.
- How much funding has Novai raised?
- Novai has disclosed $1.1M raised across 1 of its 2 known rounds.
- Where is Novai headquartered?
- Novai is headquartered in Reading, GB.